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A B S T R A C T
DEPTOR [DEP-domain-containing and mTOR (mammalian target of rapamycin)-interacting
protein] is a modulator of mTOR signalling that binds to mTORC (mTOR complex) 1 and
mTORC2. However, to date, the precise functions of DEPTOR are not fully elucidated, particularly
in reproductive tissues where mTOR acts as a placental nutrient sensor. Pregnancy is associated
with major physiological and psychosocial changes and adaptation to these changes is crucial for
normal fetal development. In the present study, we tested the hypothesis that maternal stress can
affect mTOR signalling at term, and, as a result, influence placental growth. We first investigated
the expression of DEPTOR, mTOR, rictor (rapamycin-insensitive companion of mTOR) and
raptor (regulatory associated protein of mTOR) from human placentas (n = 23) using Q-PCR
(quantitative PCR), and correlated these data to days of pregnancy and maternal stress, as well as
placental and fetal weight. Maternal and fetal cortisol levels were also measured. JEG-3 and BeWo
cells, used as placental in vitro models, were treated with cortisol and DEPTOR expression was
assessed using Q-PCR. DEPTOR appears to be the predominant transcript in the human placenta
compared with mTOR, rictor and raptor in both term (n = 13) and preterm (n = 10) placentas
as assessed by Q-PCR. There was a significantly lower level only of log-DEPTOR gene expression
in the high stress group (−1.34) than in the low stress group (0.07; t20 = 2.41, P = 0.026).
Interestingly, mothers with high stress had significantly elevated levels of cortisol (8555 pg/ml)
compared with those with low stress (4900 pg/ml). We then tested the hypothesis that cortisol
can directly affect DEPTOR expression. When BeWo cells were treated with cortisol 10, 100
and 1000 nM, the expression of DEPTOR was significantly down-regulated by 50, 41 and 39% (all
P < 0.05) respectively when compared with basal levels. Treatment of JEG-3 cells with cortisol, led
to a significant decrease of DEPTOR expression at 100 nM (39%, P < 0.05) and at 1000 nM (73%,
P < 0.01). These novel findings are indicative of a higher order of complexity of DEPTOR signalling
in the human placenta that is affected by maternal stress, which could affect pregnancy outcome.
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complex; Q-PCR, quantitative PCR; raptor, regulatory associated protein of mTOR; rictor, rapamycin-insensitive companion of
mTOR; RQ, relative quantity S6K1, S6 kinase 1.
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INTRODUCTION
A vital factor for fetal development is nutrient transport
at the placental level. This is because any disturbances
in the maternal compartments, for example due to
maternal stress or nutritional status, which will affect
fetal development, will involve the feto–placental
barrier. Interestingly, the mTOR (mammalian target
of rapamycin) is a highly conserved serine/threonine
protein kinase [1] that functions as an ATP and
amino acid sensor to balance nutrient availability and cell
growth [2]. mTOR is capable of forming two complexes
named mTORC1 and mTORC2, which differ in their
composition, are regulated in distinct ways and can exert
distinct biological effects. The rapamycin-sensitive mT-
ORC1contains the followingproteins: raptor (regulatory
associated protein of mTOR), GβL [G-protein β-like;
also known as mLST8 mammalian lethal with SEC13
protein 8)], and PRAS40 (proline-rich Akt substrate
of 40 kDa). mTORC1 regulates protein synthesis
and cell growth by phosphorylating downstream target
proteins such as p70 ribosomal S6K1 (S6 kinase 1) and the
eukaryotic initiation factor 4E-BP1 (eukaryotic initiation
factor 4E-binding protein 1) [3,4]. The rapamycin-
insensitive mTORC2 complex contains: rictor
(rapamycin-insensitive companion of mTOR), mSIN1
(stress-activated protein kinase-interacting protein 1),
Protor-1 and GβL and functions as an Akt kinase that
phosphorylates Ser473 of Akt in the ‘hydrophobic motif’
that is essential for full activation of this kinase [5–7].
Recently, another modulator of the mTOR pathway,
termed DEPTOR (DEP-domain-containing mTOR-
interacting protein) has been described. DEPTOR binds
to both mTORC1 and mTORC2, as evident from
co-immunoprecipitation experiments [8]. Its precise
function is not fully elucidated, but Peterson et al. [8]
have shown in a series of elegant experiments that
knocking down DEPTOR leads to activation of
signalling through mTORC1 and mTORC2. This is
demonstrated both by the observation that there is a
change in the phosphorylation status of S6K1 and Akt
when DEPTOR levels are decreased (by RNA-based
interference) and by the increased in vitro activity against
these substrates of mTOR complexes from cells with
decreased levels of DEPTOR [8,9]. To date, very little
is known about the involvement of DEPTOR in disease
pathogenesis. DEPTOR is down-regulated in a number
of cancers such as prostate, bladder, cervix and thyroid.
Surprisingly, DEPTOR is highly overexpressed in a
subset of multiple myelomas harbouring cyclin D1/D3
or c-MAF/MAFB translocations [8]. RSV (resveratrol) is
a naturally occurring polyphenol that has been found to
exert antioxidant, anti-inflammatory andneuroprotective
properties, and inhibits mTOR signalling by promoting
the interaction between mTOR and DEPTOR in C2C12
fibroblasts [10]. Results from our laboratory have
demonstrated a significant up-regulation of DEPTOR
in two paclitaxel-resistant ovarian cancer cell lines when
compared with the parental ones [11].
The cross-talk between the mother and the fetus
is complex as well as bidirectional. Apart from a
plethora of hormonal and immunological events that take
place during pregnancy, maternal stress is a powerful
contributor to birth outcomes. Maternal psychological
anxiety can be as a result of pregnancy-related anxiety,
depression or distress [12]. Elevated levels of maternal
anxiety have been linked with preterm labour and
low birth weight babies [13], and there is evidence
for a link between higher maternal anxiety and poor
offspring development, including problems in cognition
andbehaviour.Moreover,maternal stress is linked topoor
fetal development in utero [14,15]. Since fetal growth
is critically dependent on placental nutrient transport,
placental mTOR signalling plays an important role in
the regulation of fetal growth [16]. Recent findings
suggest that mTOR functions as an important placental
growth signalling sensor, linking maternal nutrient and
growth factor concentrations to amino acid transport
[17,18]. Moreover, in placentas from IUGR (intrauterine
growth restriction) pregnancies, the protein expression
of placental phospho-S6K1 (Thr389), a measure of the
activity of mTORC1, was significantly reduced [18]. In
an HT (hyperthermia)-induced IUGR model in sheep,
a range of changes were apparent regarding the mTOR
pathway: there was upregulation of the phosphorylation
status of placental mTOR and Akt and decrease of p70
ribosomal S6K [19]. Collectively, these results indicate
that fetal stress can affect the placental mTOR signalling
pathway [19].
However, the effects of maternal stress on fetal growth
are not consistent. In a large cohort study in Denmark,
maternal life stress during pregnancy was associated
with increased placental weight at birth [20]. Given
that mTOR can function as a human placental sensor
for nutrients and energy balance, and since maternal
stress may influence such factors, we hypothesized that
maternal stress can affect mTOR signalling at term, and,
as a result, influence placental growth. These issues were
investigated both in vivo and in vitro study using clinical
samples and placental cell lines respectively.
MATERIALS AND METHODS
Subjects
The study population consisted of pregnant women
attending the Department of Obstetrics and Gynae-
cology, University Hospital, University of Crete. The
participantswere in the third trimester of their pregnancy.
All participants gave informed consent to participate in
the study and ethical approval was granted by the local
ethics committee of the hospital.
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Table 1 Demographic details of the patients involved
in the present study
Values are means+− S.D.
Parameter Value
Height (cm) 168+− 0.04
Pre-pregnancy weight (kg) 66.0+− 18.5
BMI (kg/m2) 23.9+− 6.80
Age (years) 29.6+− 4.30
Pregnancy days 239.7+− 42.6
Placental weight (g) 406.9+− 94.9
Fetal weight (g) 2805.2+− 496.04
Maternal age category
20–24 years (n = 1) 4.35%
25–35 years (n = 22) 95.65%
Study design
This was a prospective study in which women’s
stress levels and attitude towards their pregnancy were
measured during the third trimester. All data were
collected from September 2007 to March 2008. The
women were approached for the first time by the
researchers in the prenatal clinic without knowing
about the questions. Questions were used to acquire
anthropometrical data such as gestational age, weight
before conception, current weight and height. After
delivery, the weight of the infant was recorded along
with the placental weight. A face-to-face interview was
conducted with each woman lasting at least 30 min.
There were specific questions related to the stress profile,
which included: whether the pregnancy was planned
or not planned; how stressed each woman was during
the pregnancy, with responses ranging from 1 to 4 (1
= low, 2 = medium, 3 = high, 4 = very high). This
stress questionnaire was based on a study by Wang et
al. [21] where women with dysmenorrhoea were asked to
describe their stress in preceding cycles as ‘low’, ‘medium’
or ‘high’. The demographic details are given in Table 1.
Placental tissue
Placental tissues were obtained fromwomen delivering at
term (>37 weeks of gestation) and preterm (<37 weeks of
gestation) (total n = 23). Placental tissues were obtained
from the maternal side of the placentas at a maximum of
30 min after delivery. The tissue samples taken were ap-
proximately 0.2–0.5 cm3 in size and were taken from the
centre of the cotyledons evenly across the placenta. The
tissues were dissected to remove any visible connective
tissue and calcium deposits. Following washes in PBS,
samples were immediately stored in RNAlater® (Applied
Biosystems) at − 80 ◦C. Ethical approval was granted
from the local ethics authority.Of the 23 placentas collec-
ted, 13 were term (average, 268 pregnancy days) and 10
were preterm (average, 211 pregnancy days). None of the
term or preterm women were administered any antide-
pressants or synthetic glucocorticoids during pregnancy.
Of the 13 term placentas, 12 were in labour [mode of
delivery: ten CS (Caesarean sections) and two vaginal
deliveries] and one non-labour/CS tissue. Of the ten
preterm placentas four were non-labour and all CS, and
six were from labouring tissues (mode of delivery: three
CS and three vaginal deliveries).
Cortisol measurement
Maternal non-fasting blood samples were collected
into EDTA tubes between 09.00 and 10.00 hours,
and centrifuged immediately at 525 g for 10 min. The
resulted plasma was separated and snap frozen in
dry ice and stored at − 20 ◦C until further use. The
maternal blood samples were collected on the same day
that the questionnaires were completed. Fetal blood
samples were obtained from the umbilical artery at
the time of delivery. Identical preparations to maternal
samples took place regarding plasma isolation. Plasma
cortisol levels were measured using a Cortisol EIA
(Enzo Life Sciences), a colorimetric competitive enzyme
immunoassay kit according to the manufacturer’s
instructions. The sensitivity of the assay is 56.72 pg/ml
with a range between 156 and 10000 pg/ml. The inter-
assay coefficient of variation for cortisol was 7.8% at
969 pg/ml and the intra-assay coefficient of variation for
cortisol was 6.6% at 1088 pg/ml.
Cell culture
BeWo and JEG-3 cell lines were purchased from the
European Collection of Cell Cultures. The cells were
maintained at standard culture conditions of 5% CO2
in air at 37 ◦C. BeWo cells were cultured in Ham’s
F12 (Sigma) containing 10% heat-inactivated FBS
(fetal bovine serum) and 0.5% penicillin/streptomycin,
whereas JEG-3 cells were maintained in MEME
[MEM (minimal essential medium) Eagle] (Sigma)
containing 10% heat-inactivated FBS, 0.5% penicil-
lin/streptomycin, 0.5% l-glutamine, 0.5% sodium
pyruvate and 0.5% MEM non-essential amino acids.
Prior to treatment, both cell lines were maintained for 3 h
in Phenol Red-free medium containing charcoal-stripped
FBS.
Cortisol treatments
BeWo and JEG-3 cells were treated overnight with 10,
100 and 1000 nM cortisol in an attempt to mimic stress
response in vitro. The concentrations were chosen in ac-
cordance with previous studies [22–26] that demonstrate
that 10 and 100 nM cortisol doses simulate stress condi-
tions and resemble physiological levels of the circulating
steroid,whereas 1000 nMmimics a pharmacological dose.
For these treatments, a vehicle-only controlwas alsoused.
Immunofluorescent analysis of BeWo and
JEG-3 cells
BeWo and JEG-3 cells were fixed in 4% paraform-
aldehyde for 10 min prior to washes in PBS and
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Table 2 Primers used for Q-PCR studies
Gene Expected size (bp) Primer sequence
DEPTOR 202 Forward, 5′-CACCATGTGTGTGATGAGCA-3′
Reverse, 5′-TGAAGGTGCGCTCATACTTG-3′
Rictor 117 Forward, 5′-GGAAGCCTGTTGATGGTGAT-3′
Reverse, 5′-GGCAGCCTGTTTTATGGTGT-3′
Raptor 170 Forward, 5′-ACTGATGGAGTCCGAAATGC-3′
Reverse, 5′-TCATCCGATCCTTCATCCTC-3′
mTOR 135 Forward, 5′-TGCCAACTATCTTCGGAACC-3′
Reverse, 5′-GCTCGCTTCACCTCAAATTC-3′
β-Actin 216 Forward, 5′-AAGAGAGGCATCCTCACCCT-3′
Reverse, 5′-TACATGGCTGGGGTGTTGAA-3′
incubation with 10% BSA for 1 h. Cells were incubated
for 1 h with an anti-DEPTOR antibody (Millipore)
at a 1:100 dilution in 1% BSA/PBS. Cells were then
washed with PBS prior to a further incubation with
a FITC-conjugated anti-(rabbit IgG) antibody (Santa
Cruz Biotechnology) for 1 h. Slides were washed with
PBS and mounted in Vectashield® Mounting Medium
(Vector labs) containing the dye DAPI (4′,6-diamidino-
2-phenylindole) to counterstain nuclei. Images were
captured using a Plan Apo Neofluor 63× 1.25 NA
(numerical apperture) oil objective (Zeiss) on a Zeiss
Axiovert 200 Mmicroscope and viewedusingAxioVision
software.
RNA isolation, cDNA synthesis and PCR
Total ribonucleic acid was isolated using an RNA
extraction kit (Sigma), according to the manufacturer’s
instructions. RNA concentration was determined by
spectrophotometric analysis (NanoDrop; Thermo Sci-
entific) and agarose gel electrophoresis. RNA (200 ng
from placental tissue and 500 ng from cell lysates)
was reverse-transcribed into cDNA using 5 I.U.
(international units)/μl RNase H reverse transcriptase
(Invitrogen).
Q-PCR (quantitative PCR)
Relative expression of the genes of interest was
assessed by Q-PCR on an ABI Prism 7900HT
Sequence detection system (Applied Biosystems) using
SYBR® Green-PCR reaction mixture (Sigma–Aldrich)
and specific primers (Table 2). As a negative control,
distilled water was used in place of the cDNA.
For the Q-PCR, the following equations were used:
Ct = Ct (gene of interest) −Ct (housekeeping gene), Ct =
Ct (sample) −Ct (calibrator), The RQ (relative quantity) =
2−Ct. The RQ value was set up as 1 for the untreated
(no supplement) BeWo and JEG-3 cells. We have also
calculated the gene expression levels as RQ values, using
the untreated control for each cell line as a calibrator.
We did so, since RQ values provide a more accurate
comparison between the initial amounts of template in
each sample, without requiring an exact copy number
for analysis. Q-PCR data are reported as means+− S.E.M.
Statistical analysis of the Ct values was performed
by one-way ANOVA, followed by Bonferroni multiple
comparison as a post-hoc test using GraphPad Prism 5.0.
Immunofluorescent analysis of placental
sections
Following a series of deparaffinization and dehydration
steps, placental tissue sections were incubated with 10%
BSA for 1 h. This was followed by incubation for 1 hwith
antibodies against DEPTOR (Millipore), mTOR, raptor
and rictor (Cell Signaling Technology) at a 1:200 dilution
in 1% BSA/PBS. Cells were then washed with PBS prior
to an incubation with a TRITC (tetramethylrhodamine
β-isothiocyanate)-conjugated secondary antibody (Santa
Cruz Biotechnology) for 1 h. Slides were washed with
PBS and mounted in Vectashield® Mounting Medium
(Vector labs) containing the dye DAPI to counterstain
nuclei. Images were captured using a Plan Apo Neofluor
63× 1.25 NA (numerical apperture) oil objective (Zeiss)
on a Zeiss Axiovert 200M microscope and viewed
using AxioVision software. The images were then
analysed using Image J 1.34s image-analysis software
(National Institutes of Health). Results are presented as
means+− S.D. Statistical comparisons between the BeWo
and JEG-3 cells were performed using a Student’s t test.
Differences between means were considered significant
when P< 0.05.
Statistical analysis
For the correlation studies, a two-tailed test using SPSS
(Version 18) was used. A P 0.05 was regarded as
significant. For the correlation studies between gene
expression and clinical data, DEPTOR, mTOR, rictor
and raptor expression were log transformed in order
to acquire a normal distribution. For analysis of gene
expression and categorical data (groups of stress levels),
Student’s t tests were used. We also tested by the more
stringent ANCOVA (analysis of co-variance) the effects
of categorical stress (high/low) on levels of DEPTOR,
adjusting for confounders either related to DEPTOR or
to stress, as covariates.
RESULTS
Expression of DEPTOR, mTOR, rictor and
raptor and correlation analyses in human
placentas
Q-PCR revealed that DEPTOR, mTOR, rictor and
raptor are expressed in the human placenta (n = 23).
DEPTOR is the primary transcript in the total cohort of
patients with a Ct of 5.021 compared with 0.1040
of mTOR (P= 0.0126), 0.7993 of rictor (P= 0.0315) and
0.412 of raptor (P= 0.0193). From the 23 placentas, 13
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Figure 1 Q-PCR analysis of DEPTOR, mTOR, rictor and
raptor in human placentas revealed that DEPTOR is the
predominant gene among mTOR signalling components
C t = C t (gene of interest) − C t (β-actin) ; ∗P < 0.05 compared with DEPTOR.
were term labour (<37 weeks of gestation) and
ten were preterm (>37 weeks of gestation) labour. When
Ct values were analysed in these two categories,
DEPTOR was the predominant transcript. In term
labour, Ct for DEPTOR was 3.939 compared with
0.09343 for mTOR, 0.7898 for rictor and 0.3345 for
raptor (Figure 1). In preterm placentas, the values were
6.428, 0.1178, 0.8117 and 0.5339 for DEPTOR, mTOR,
rictor and raptor respectively. There was a significant
correlation between log-transformed DEPTOR and
raptor (r = 0.729, P< 0.005), and rictor with raptor (r =
0.661, P= 0.014) only in the preterm placentas examined.
We have also analysed the Ct levels in terms of the
contractile status (labour, n = 18; or non-labour, n = 5).
In placental tissues obtained during labour the Ct for
DEPTOR was 5.241 compared with 0.09739 for mTOR,
0.7142 for rictor and 0.4246 for raptor. In non-labouring
placentas, the values were 4.228, 0.1280, 1.106 and 0.4027
for DEPTOR, mTOR, rictor and raptor respectively.
In this cohort (i.e. in 23 patients), 52% reported high
and very high levels of stress during pregnancy, and 48%
mediumand low levels. Therewas no correlation between
maternal stress levels and BMI (body mass index). How-
ever, therewas a very strong correlationbetweenplacental
and fetal weight (r = 0.986, P< 0.0001) and between days
of pregnancy and fetal and placental weight (r= 0.968 and
r = 0.942 respectively; P< 0.0001). Interestingly, there
was a significantly lower level of log-DEPTOR gene
expression in the high stress group (−1.34) than in the
low stress group (0.07; t20 = 2.41, P= 0.026).
Corresponding fetal plasma cortisol levels were also
measured. Mothers with high stress had significantly
(P= 0.035) elevated levels of cortisol (8555+− 925 pg/ml)
compared with those with low stress (4900+− 1700
pg/ml.) The average pregnancy days for the high stress
group was 223.2+− 60, whereas the average gestational
period for the low stress group was 253.7+− 23 days.
The fetal cortisol from mothers with high stress was
measured to be 7440+− 1349 pg/ml, whereas fetal cortisol
from mothers with low stress was measured to be
7525+− 1173 pg/ml. There was no significance among
the two groups (P> 0.4). Interestingly, a significant
positive correlation between maternal and fetal cortisol
was detected in the high but not the low stress group
(r= 0.678, P= 0.022). In the high stress group, there
was also a significant inverse correlation between fetal
cortisol and placental weight (r= − 0.638, P= 0.024)
as well as fetal weight (r = − 0.642, P= 0.023). In
the low stress group there was a significant correlation
between fetal cortisol and placental weight (r =
0.804, P= 0.029) as well as fetal weight (r = 0.784,
P= 0.037). There was a significant correlation between
placental and fetal weight both in the high (r = 0.983,
P< 0.0001) and low maternal stress groups (r = 0.870,
P< 0.011). Finally, umbilical cord (fetal) samples did not
vary significantly between the term (8254+− 949 pg/ml)
and preterm groups (6341+− 1822 pg/ml, P> 0.1).
We then assessed whether time of delivery has an
effect. In term tissues (n = 13) high stress inversely
correlated with log-DEPTOR levels (r = − 0.772, P=
0.002), placental weight (r = − 0.591, P= 0.03) and
fetal weight (r= − 0.732, P= 0.004). In the same cohort,
log-DEPTOR levels positively correlated with placenta
weight (r = 0.497, P= 0.084) and fetal weight (r =
0.616, P = 0.025). In pre-term placentas (n = 10)
maternal high stress levels inversely correlated only
with placental weight (r = − 0.621, P= 0.07) and fetal
weight (r = − 0.695, P= 0.038). Interestingly, in this
group, log-DEPTOR levels inversely correlated with
placental weight (r = − 0.622, P= 0.055) and fetal
weight (r= − 0.575, P= 0.082). Given the effects of
timing of delivery on stress, we retested the main
hypothesis. An ANCOVA was used to test whether
low/high stress correlates with DEPTOR, controlling
for contractile status (labour/non-labour) and timing of
labour (term/preterm) entered as covariates. Taking these
confounders into consideration, we still found a trend
towards a significant relation between high stress and
DEPTOR: F1,18 = 4.12, P= 0.055.
Finally, we have also taken into consideration the
smoking status of our patients before and during
pregnancy. Of the 23 women, 17 did not smoke (74%)
and six did (26%) before pregnancy. During pregnancy,
19 did not smoke (83%),whereas only four kept smoking
(17%). Placental DEPTOR levels were not statistically
different in the two groups regarding smoking status
during pregnancy.
Cellular localization of DEPTOR, mTOR,
rictor and raptor in human placenta
Immunofluorescent analysis of the mTOR signalling
components in human placental tissue sections revealed
the cellular localization and distribution of each of the
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components individually. The expression of DEPTOR
was almost exclusively localized in the syncytium layer
exhibiting a strong cytoplasmic localization. Staining was
also visible in the cytoplasm of the cytotrophoblast cells
beneath the syncytium layer. mTOR staining revealed
a cytoplasmic expression not only in the syncytium
layer but also in the cytoplasm of the cytotrophoblast
cells. rictor appeared to have a similar expression pattern
to mTOR, showing expression in the cytoplasm of
both the syncytium layer and the cytotrophoblast cells.
The expression of raptor was observed mainly in the
syncytium layer, with staining observed in the cytoplasm
(Figure 2).
Expression of DEPTOR in BeWo and
JEG-3 cells
DEPTOR expression in two placental cell lines was
then assessed. Prior to Q-PCR analysis, the control
gene expression was assessed. An identical amount of
RNA (500 ng) was reverse transcribed and analysis of
the housekeeping gene β-actin revealed identical Ct for
both cell lines (Figure 3A). Moreover, melting curve
peak analysis demonstrated an identical peak and area
under curve (Figure 3B). These data suggest that, by
having an identical control gene, meaningful comparisons
between the two cell lines can be made. Q-PCR and
immunofluoresce analysis demonstrated for the first time
expression of DEPTOR in both cell lines at the mRNA
and protein levels. Q-PCR revealed that DEPTOR is
overexpressed in BeWo cells when compared with JEG-3
under basal conditions (2.5-fold, P< 0.01, Figure 3C).
Densitometric analysis of the immunostaining corrob-
orated theQ-PCR data, as it demonstrates higher protein
expression of DEPTOR in BeWo (46.4+− 4.3 units) when
compared with JEG-3 cells (24.6+− 4.8 units; Figure 4A).
The cellular distribution of DEPTOR in the two cell
lines revealed a cytoplasmic localization. In BeWo cells,
DEPTOR is seen mainly around the nucleus, whereas,
in JEG-3 cells, a more dispersed cytoplasmic staining is
evident (Figures 4B–4E).
Effects of cortisol on DEPTOR in BeWo
and JEG-3 cells
Given the inverse relationship of stress and DEPTOR
in our clinical samples, we tested the hypothesis that
cortisolmight affectDEPTORexpression directly. BeWo
and JEG-3 cells were treated overnight with cortisol,
in an attempt to resemble a moderate and high stress
environment in vitro.When BeWo cells were treatedwith
cortisol 10, 100 or 1000 nM, the expression of DEPTOR
was significantly down-regulated by 50, 41 and 39% (all
P< 0.05) respectively when compared with basal levels
(Figure 5A). Treatment of JEG-3 cells with cortisol led to
a significant decrease of DEPTOR expression at 100 nM
(39%, P< 0.05) and at 1000 nM (73%, P< 0.01) when
Figure 2 Immunofluorescent analysis of DEPTOR, mTOR,
rictor and raptor in human placentas
Immunofluorescent analysis showing strong cytoplasmic localization present in the
syncytium layer for DEPTOR, whereas mTOR and rictor were expressed in both
cytotrophoblasts cells and the syncytium layer with the staining being cytoplasmic.
raptor revealed a cytoplasmic staining present in the syncytium layer. Control:
immunofluorescent analysis of placental section in which the primary antibody
has been omitted indicates specificity of the fluorescent signal detected for the
mTOR signalling components. Magnification, ×40.
compared with basal levels as well (Figure 5B). However,
cortisol treatments did not exert any significant changes
in the gene expression of mTOR, rictor or raptor in both
cell lines (results not shown).
DISCUSSION
In the present study, we provide novel evidence of
a bio-behavioural cross-talk of mTOR signalling at
placental level. Pregnancy is associated with major
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Figure 3 Differential expression of DEPTOR in BeWo and JEG-3 cells
(A) C t values for the housekeeping gene β-actin reveal identical amplification efficiency for both BeWo and JEG-3 cells. (B) Melting curve analysis for β-actin in both
cell lines, demonstrates a single melting peak at identical temperature. (C) Q-PCR demonstrates that DEPTOR is significantly expressed in BeWo cells when compared
with JEG-3; ∗∗P < 0.01.
physiological and psychosocial changes and adaptation
to these changes is crucial for normal fetal development
[27,28]. Pregnancy-specific stressmaybe amorepowerful
contributor to birth outcomes than general stress [29].
In this study, 23 pregnant women self-reported their
stress status ranging from low and medium (low stress
response) to high and very high (high stress response).
The source of the stress was not reported. Generally,
maternal stress could be due to lack of social support,
anxiety about the pregnancy outcome or environment-
related stressful conditions [28]. Nepomnaschy et al. [30],
have suggested that human placentation is an important
period for examining the relationship between maternal
stress and pregnancy outcome. Indeed a major finding in
our study was the significant inverse correlation between
mRNA levels of placental DEPTOR and self-reported
stress levels. None of the other mTOR components
displayed any correlation with stress. It should be noted
that the levels of self-reported stress were evaluated only
at the third trimester. In a study of 1800 women [12]
the different levels of life events stress during pregnancy
were analysed. The authors concluded that there were
substantial differences of prenatal life events stress in the
third trimester of pregnancy, as a function of educational
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Figure 4 Down-regulation of DEPTOR protein in JEG-3
compared with BeWo cells
(A) Densitometric analysis of DEPTOR revealed a notable up-regulation at the
protein level in BeWo cells when compared with JEG-3, mirroring the changes
seen at gene level using Q-PCR. (B and C) Immunofluorescent analysis of DEPTOR
in BeWo and JEG-3 cells respectively revealed cytoplasmic localization in both
cell lines. Circles in (B) and (C) indicate the same amount of cells used for
densitometric analysis as in (A). Images were analysed using Image J 1.34s
image-analysis software (∗∗P < 0.001). Results are presented as means+− S.E.M.
(D and E) Negative controls of (B and C) where the primary antibody has been
omitted, demonstrating staining specificity.
background and maternal age [12]. However, prenatal
severe life events in the first and second but not third
trimester were associated with an increased risk of
preterm birth [12]. Although most studies suggest that
prenatal maternal stress predicts adverse infant outcomes
[13–15], the large-scale Danish study found maternal
stress to predict greater infant birthweight [20]. The exact
role of DEPTOR is relatively unknown, but emerging
data suggest it plays a role in certain cells’ survival [8].
Thus it is possible that, via reduced DEPTOR, stress
could lead to alterations in placental growth that can
impact on fetal development.
Preterm birth is the most important problem in
maternal/child health.Numerous epidemiological studies
suggested that maternal stress is associated significantly
with the onset of spontaneous preterm birth [31]. Despite
Figure 5 Quantitative analysis of DEPTOR levels in BeWo
and JEG-3 cells following 24 h of cortisol treatment
(A) Cortisol treatment of BeWo cells induced a significant (∗P < 0.05)
down-regulation of DEPTOR (NS = no supplement). (B) In JEG-3 cells, cortisol
induced a dose-dependent down-regulation of DEPTOR that reached significance
at 100 nM (∗P < 0.05) and 1000 nM (∗∗P < 0.01) when compared with no
supplement.
extensive research, the mechanisms that drive this are
still poorly understood. As a result, the prevalence
rate of preterm birth still remains high. In our study,
we provide evidence for a dual role of DEPTOR
in at-term and preterm placentas. We would like to
propose the following model: in at-term placentas (i.e.
normal uncomplicated pregnancies) high stress inversely
correlates with DEPTOR. Previous evidence suggests
that DEPTOR exerts a selective inhibitory effect on
mTORC1 signalling relative to mTORC2 [8,9]. Our
findings provide novel evidence of this, as in this
cohort DEPTOR strongly associates with raptor, a key
component of mTORC1 complex, but not with rictor.
To the best of our knowledge this is a first time
that such an association has been shown in clinical
samples. It is possible that the tight association of these
molecules compromised the function of mTORC1. The
net result still would be a decrease in cell growth
that might contribute towards the low placental weight.
These findings corroborate a previous study that indeed
indicates asymmetry in the actions of DEPTOR [8]. For
example, in a vast array of cancers DEPTOR is down-
regulated, resulting in an increased rate of tumorigenesis
and cell proliferation. However, in multiple myelomas
DEPTOR depletion inhibited the proliferation of these
cells and led to subsequent apoptotic events. In preterm
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labour, the dynamics are altered. Stress is no longer
inversely associated with DEPTOR and this will result
in permanently elevated levels of DEPTOR. Indeed, the
Q-PCR data indicate that the expression of DEPTOR
is higher in preterm samples. Moreover, there is no
association between DEPTOR and raptor. The net
effect would be an exacerbated inhibitory action of
DEPTOR to mTORC1 accounting for the decrease in
placental cell proliferation and thus the overall decrease
in placental weight seen in preterm placentas. This dual
role provides evidence of a high order of complexity
regarding DEPTOR signalling, possibly involving post-
translational modifications or co-regulation of mTOR
gene complexes as it is evident in these clinical samples.
Glucocorticoids are key mediators of stress responses
and can act as mediators of fetal development. They
are responsible for the intrauterine maturation of tissues
and organs, promoting cellular differentiation [32]. In
pregnancies complicated by IUGR, fetal cortisol levels
are elevated at term [33], associating reduced fetal growth
rates with elevated glucocorticoids.Moreover, alterations
in glucocorticoid signalling in early life can induce
persistent effects on later phenotype and disease risk [32].
Several studies have also documented an increase of the
endogenous levels of cortisol with pregnancy [34,35].
However, due to different methodological approaches,
the cortisol values tend to vary. For example, one
group has shown that cortisol values varied between
13 and 46 nmol/l when sampled at 37 and 38 weeks of
pregnancy. The average cortisol levels were 25.3 nmol/l
[36].However, in another study [37], a greater variation of
cortisol levels in late pregnancy was noted, ranging from
3.7 to 55 nmol/l with amedian of 11.80 nmol/l.Moreover,
no apparent correlation between maternal cortisol levels
with preterm labour and preterm birth was noted at any
gestational age. In the latter study, cortisol levels peaked
towards the end of pregnancy (31–35 weeks), reaching an
average of approximately 33 ng/ml for those delivered at
term [35].
Given the importance of cortisol as a stress marker, we
hypothesized that it might affect DEPTOR expression
directly. We tested this in vitro, employing two well
established choriocarcinoma cell lines (BeWo and JEG-
3) that have been used widely to decipher placental
signalling. Both cell lines were treated over 24 h with
10, 100 and 1000 nM of cortisol in an attempt to
resemble moderate, high and very high stress levels.
Treatment of JEG-3 cells with cortisol resulted in a
dose-dependent down-regulation of DEPTOR, reaching
significance at 100 and 1000 nM. However, when the
same treatments were repeated in BeWo cells, dose-
dependence was not observed. This could be due to
inherent differences that these two cell lines appear to
possess. Microarray analyses revealed that up to 2700
genes are differentially expressed between the two cell
lines [38]. Interestingly, principal differences observed in
various biological processes, including response to stress
and signal transduction, where noted [18]. In our study,
we demonstrate that DEPTOR is expressed in higher
amounts in BeWo cells than in JEG-3 cells. It is possible
that this overexpression is responsible for the weaker
down-regulation of DEPTOR by cortisol in this cell line.
We would also like to acknowledge that our study
has a number of limitations. The clinical sample is
relatively small and comes from a relatively homogeneous
population of a Greek island. In the study by Ruiz et al.
[35], higher maternal cortisol levels were observed in the
Hispanic group when compared with Anglo-Americans.
To date, there are no data regarding any ethnic variation
of maternal cortisol in the Greek population. However,
the relative uniformity of our sample could also have
certain advantages – we do not need to control for the
effects of other factors/variables such as lifestyle, diet
and ethnicity, as these may have been rather similar
among participants. In addition, the measurement of self-
reported stress was rather crude in nature. Given the
emerging data of the current study, it will be interesting to
dissect the exact nature of the stress response (i.e. life event
stress and subtypes, appraisal of stress controllability
and pregnancy-related anxiety) as reported previously
[31]. Signs of fetal distress should also be taken into
account in future studies as our present findings lack
an association with the APGAR score. Moreover, our
in vitro results were generated by the use of two human
choriocarcinoma cell lines (BeWo and JEG-3). These
experiments should be repeated in placental explants or
primary placental trophoblasts, and perhaps at a wider
dose range of cortisol, to gain a better insight into the
role of cortisol in such cells. For example, the effect
seen in BeWo cells was not dose-dependent as 10 nM
of cortisol appeared to suppress DEPTOR expression
similarly to 100 and 1000 nM. However, this was not
the aim of our study, as we treated both cell lines with
concentrations that would simulate stress conditions.
Finally, we would also like to acknowledge certain
controversy regarding use of housekeeping genes for Q-
PCR analysis [39]. We have performed a comparative
Q-PCR where we show that in our clinical samples the
Ct of β-actin and 18 sRNA (small non-coding RNA)
were almost identical and therefore the RQ readings and
significance (RQ = 2−Ct) were not altered (results not
shown). Nevertheless, our findings from two different
methodologies (in vivo and in vitro) point to a possible
role of prenatal maternal stress in the expression of
DEPTOR, and the significance of this finding in fetal
development requires further investigation.
Future research should concentrate on dissecting the
effects of cortisol at the protein level. For example,
it will be of interest to assess effects of cortisol
at the post-translational level (i.e. alterations of the
phosphorylation status of DEPTOR and other mTOR
components). Moreover, the impact of this treatment
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in the aggregation and subsequent stoichiometry
of mTORC1 and mTORC2 complexes should also
be elucidated. Collectively, the in vitro findings in
combination with the clinical data suggest that stress and
the stress hormone cortisol may be potent modulators
of DEPTOR at the placental level. As a result, it
is attractive to speculate that maternal stress might
affect subsequent placental mTOR signalling events, with
possible consequences for fetal development.
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